down arrow

J B Chemicals &

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE572A01036
  • NSEID: JBCHEPHARM
  • BSEID: 506943
INR
1,572.10
37.1 (2.42%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 62.9 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About J B Chemicals & Pharmaceuticals Ltd stock-summary
stock-summary
J B Chemicals & Pharmaceuticals Ltd
Large Cap
Pharmaceuticals & Drugs
J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs. The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
Company Coordinates stock-summary
Company Details
Neelam Centre 4th Floor, B-Wing Hind Cycle Road Worli Mumbai Maharashtra : 400030
stock-summary
Tel: 91-022-2482 2222/2493 0918
stock-summary
investorelations@jbcpl.com / secret
Registrar Details
Datamatics Financial Services Ltd , (Formerly Datamatics Financial Services Ltd) , Plot No A / 16 & A / 17, MIDC, Part B, Cross Lane, Marol , Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 15.53 Cr
Number of Shares
15.53 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Sep-2024
15.53
15.53
20000
1
Issued under ESOP Scheme
27-Aug-2024
15.53
15.53
69850
1
Issued under ESOP Scheme
08-Aug-2024
15.52
15.52
11500
1
Issued under ESOP Scheme
04-Jun-2024
15.52
15.52
11582
1
Issued under ESOP Scheme
11-May-2024
15.52
15.52
6676
1
Issued under ESOP Scheme
05-Mar-2024
15.52
15.52
43450
1
Issued under ESOP Scheme
05-Feb-2024
15.52
15.52
107190
1
Issued under ESOP Scheme
29-Nov-2023
15.5
15.50
10210
1
Issued under ESOP Scheme
07-Nov-2023
15.5
15.50
78440
1
Issued under ESOP Scheme
18-Sep-2023
15.49
15.49
77464010
1
Stock Split
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 29 Schemes (14.57%)

FIIs

Held by 239 FIIs (14.64%)

Promoter with highest holding

Tau Investment Holdings Pte. Ltd. (53.66%)

Highest Public shareholder

Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap Fund (3.16%)

Individual Investors Holdings

13.42%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Padmini Khare Kaicker
Non-Exec. & Independent Dir.
75.0 lacs
Sumit Bose
Non-Exec. & Independent Dir.
75.0 lacs
Ranjit Shahani.
Chairman & Independent Directo
80.0 lacs
Prashant Kumar.
Non-Exec & Non-Independent Dir
0
Nikhil Chopra
Whole Time Director & CEO
6.54 cr
GAURAV TREHAN
Non-Exec & Non-Independent Dir
0
SANDEEP PHADNIS
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Traded Goods
167.3984
0%
 
100
Purchase of Traded Goods
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals
1,452.08
96.73%
Other Operating Revenues - Export Incentives
29.25
1.95%
Exchange Rate Difference
10.86
0.72%
 
96.73
Pharmaceuticals
3.27
Pharmaceuticals
1.95
Other Operating Revenues - Export Incentives
98.05
Other Operating Revenues - Export Incentives
0.72
Exchange Rate Difference
99.28
Exchange Rate Difference
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
963 Cr
(Quarterly Results - Dec 2024)
Net Profit:
162 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 24,474 Cr (Large Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.99%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

19.03%

stock-summary
Price to Book

7.44